Last updated on June 2019

High Strength Cranberry Supplementation for Prevention of Recurrent Urinary Tract Infection

Brief description of study

This clinical trial is a Phase 2, multicenter, placebo-controlled, double-blind, parallel-arm study to evaluate the efficacy and safety of High Strength Cranberry (500mg Pacran) in preventing UTI (cystitis) in women with a history of recurrent UTI (rUTI).

Clinical Study Identifier: NCT03042273

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.